7th Targeted Protein Degradation & Induced Proximity Summit

Propelling PROTACs, Glues, & Novel TACs Drugs Towards the First Approval

With a flurry of high capital collaborations and partnership deals from the likes of C4T, Merck KgGA, Monte Rosa, Proxygen, Orum, and momentum building in clinic with BTK degraders, ER degraders and many more assets. It has never been more import to re-join forces at the 7th TPD & Induced Proximity Summit, the longest standing and most comprehensive protein degradation and proximity based conference.

Spanning foundational research and discovery, through to IND-filing and clinical trials, this is the world’s definitive meeting to discuss opportunities and challenges the TPD & Induced Proximity field must address to expand the target space and facilitate the discovery and development of therapeutically relevant degraders, blockers, stabilizers and inducers of protein-protein interactions. Whether you’re entering the TPD & Induced Proximity space for the first time or a well-seasoned TPD veteran, this forum will equip you with the knowhow and connections to make rapid advances in your work.

Assembling over 550 TPD & Induced Proximity enthusiasts from across every corner of the landscape, we have left no stone unturned in our duty to continue to deliver the full breadth and depth of protein degradation and modulation research with SureTACs, EpiTACs, RIPTACs, Molecular Gates, and so much more.

The 7th TPD & Induced Proximity Summit is the field’s singular, one-stop-shop to gain unparalleled overview of cutting-edge R&D, whilst diving deep into end-to-end development strategy to propel degraders towards the first clinical approval.

FULL EVENT GUIDE

BROCHURE SS

Brand New Presenting Companies for This Year:

47978 - web banners

Previous Winners of the Annual TPD Awards:

INNOVATION AWARD➡️

LEADERSHIP AWARD➡️

STAND OUT SERVICE PROVIDER➡️

IMPACT
AWARD➡️

Contact Us Page (13)

Kymera Therapeutics

Contact Us Page (12)

Danette Daniels

Contact Us Page (15)

Promega

Contact Us Page (16)

Nurix Therapeutics

Event in Numbers:

500+

ATTENDEES

200+

COMPANIES

80+

WORLD-LEADING SPEAKERS

4

CONTENT-FILLED DAYS

3

TIMELINE-FOCUSED TRACKS

2024 Partners:

Expertise Partner:

Program Partners:

Innovation Partners:

Exhibition Partners:

Industry Partners:

Event Partner:

Other Events in the Small Molecules & TPD World Series